Poly Medicure Limited posted steady growth in its consolidated earnings for the quarter ended June 30, 2025.
Revenue from operations rose to ₹403.21 crore in Q1 FY26, a 4.8% increase from ₹384.78 crore in Q1 FY25, driven by sustained demand for its medical devices across key markets.
Total income stood at ₹444.90 crore, up 5.2% from ₹422.75 crore a year ago. Profit before tax surged 26.3% YoY to ₹122.94 crore from ₹97.28 crore, reflecting strong operational efficiency and cost management. Net profit climbed 25.8% to ₹93.08 crore from ₹74.03 crore.
EBITDA rose 2.3% YoY to ₹106 crore from ₹104 crore, while the operating margin came in at 26.3% compared to 26.9% in the same quarter last year, indicating stable profitability despite a slight dip in margins.
In the meantime, Poly Medicure shares traded in a range-bound manner today, hitting a low of ₹1,909.90 and a high of ₹1,999.00. The stock opened at ₹1,939.90, slightly higher than its previous close of ₹1,936.20. Over the past year, Poly Medicure has seen significant volatility, with its 52-week low at ₹1,817.00 and a high of ₹3,357.80.
